119 related articles for article (PubMed ID: 37013285)
1. Tumour infiltrating lymphocytes in colorectal cancers- correlation with tumour biology and clinical outcome: A cohort study.
Mangi FH; Shaikh TA; Qureshi JN; Ujjan ID; Syed BM
J Pak Med Assoc; 2022 Nov; 72(11):2193-2197. PubMed ID: 37013285
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.
Classe M; Burgess A; El Zein S; Wassef M; Herman P; Mortuaire G; Leroy X; Malouf GG; Verillaud B
Histopathology; 2019 Dec; 75(6):853-864. PubMed ID: 31306501
[TBL] [Abstract][Full Text] [Related]
3. The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.
Berntsson J; Svensson MC; Leandersson K; Nodin B; Micke P; Larsson AH; Eberhard J; Jirström K
Int J Cancer; 2017 Oct; 141(8):1654-1666. PubMed ID: 28677162
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of tumour-infiltrating lymphocytes as a prognostic factor in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Ruangritchankul K; Sandison A; Warburton F; Guerrero-Urbano T; Reis Ferreira M; Lei M; Thavaraj S
Histopathology; 2019 Jul; 75(1):146-150. PubMed ID: 31144335
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory receptor CD94/NKG2A on CD8
Eugène J; Jouand N; Ducoin K; Dansette D; Oger R; Deleine C; Leveque E; Meurette G; Podevin J; Matysiak T; Bennouna J; Bezieau S; Volteau C; Thomas WEA; Chetritt J; Kerdraon O; Fourquier P; Thibaudeau E; Dumont F; Mosnier JF; Toquet C; Jarry A; Gervois N; Bossard C
Mod Pathol; 2020 Mar; 33(3):468-482. PubMed ID: 31409873
[TBL] [Abstract][Full Text] [Related]
6. Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation.
Williams DS; Mouradov D; Newman MR; Amini E; Nickless DK; Fang CG; Palmieri M; Sakthianandeswaren A; Li S; Ward RL; Hawkins NJ; Skinner I; Jones I; Gibbs P; Sieber OM
Mod Pathol; 2020 Jul; 33(7):1420-1432. PubMed ID: 32047231
[TBL] [Abstract][Full Text] [Related]
7. The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.
Dawson H; Koelzer VH; Karamitopoulou E; Economou M; Hammer C; Muller DE; Lugli A; Zlobec I
Histopathology; 2014 Mar; 64(4):577-84. PubMed ID: 24111856
[TBL] [Abstract][Full Text] [Related]
8. Infiltration of mononuclear inflammatory cells into primary colorectal carcinomas: an immunohistological analysis.
Håkansson L; Adell G; Boeryd B; Sjögren F; Sjödahl R
Br J Cancer; 1997; 75(3):374-80. PubMed ID: 9020482
[TBL] [Abstract][Full Text] [Related]
9. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer.
Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL
J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333
[TBL] [Abstract][Full Text] [Related]
10. Tumor-infiltrating Immune Cells in H&E-stained Sections of Colorectal Cancer Tissue as a Reasonable Immunological Biomarker.
Matsutani S; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Iseki Y; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
Anticancer Res; 2018 Dec; 38(12):6721-6727. PubMed ID: 30504382
[TBL] [Abstract][Full Text] [Related]
11. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration.
Takemoto N; Konishi F; Yamashita K; Kojima M; Furukawa T; Miyakura Y; Shitoh K; Nagai H
Jpn J Clin Oncol; 2004 Feb; 34(2):90-8. PubMed ID: 15067103
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients.
Aasebø K; Bruun J; Bergsland CH; Nunes L; Eide GE; Pfeiffer P; Dahl O; Glimelius B; Lothe RA; Sorbye H
Br J Cancer; 2022 Jan; 126(1):48-56. PubMed ID: 34671130
[TBL] [Abstract][Full Text] [Related]
13. Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7.
Maxwell-Armstrong CA; Durrant LG; Robins RA; Galvin AM; Scholefield JH; Hardcastle JD
Gut; 1999 Oct; 45(4):593-8. PubMed ID: 10486371
[TBL] [Abstract][Full Text] [Related]
14. PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.
Rosenbaum MW; Bledsoe JR; Morales-Oyarvide V; Huynh TG; Mino-Kenudson M
Mod Pathol; 2016 Sep; 29(9):1104-12. PubMed ID: 27198569
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Tumor-Infiltrating Lymphocytes in Primary and Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.
Kong JC; Guerra GR; Pham T; Mitchell C; Lynch AC; Warrier SK; Ramsay RG; Heriot AG
Dis Colon Rectum; 2019 Apr; 62(4):498-508. PubMed ID: 30844974
[TBL] [Abstract][Full Text] [Related]
16. A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
Iseki Y; Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
PLoS One; 2018; 13(4):e0192744. PubMed ID: 29698402
[TBL] [Abstract][Full Text] [Related]
17. Development and initial validation of a deep learning algorithm to quantify histological features in colorectal carcinoma including tumour budding/poorly differentiated clusters.
Pai RK; Hartman D; Schaeffer DF; Rosty C; Shivji S; Kirsch R; Pai RK
Histopathology; 2021 Sep; 79(3):391-405. PubMed ID: 33590485
[TBL] [Abstract][Full Text] [Related]
18. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
Amicarella F; Muraro MG; Hirt C; Cremonesi E; Padovan E; Mele V; Governa V; Han J; Huber X; Droeser RA; Zuber M; Adamina M; Bolli M; Rosso R; Lugli A; Zlobec I; Terracciano L; Tornillo L; Zajac P; Eppenberger-Castori S; Trapani F; Oertli D; Iezzi G
Gut; 2017 Apr; 66(4):692-704. PubMed ID: 26719303
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
[TBL] [Abstract][Full Text] [Related]
20. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
